Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

14.50 +0.27 (+1.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,068,689
Open 14.64
Bid (Size) 14.10 (100)
Ask (Size) 14.50 (100)
Prev. Close 14.23
Today's Range 14.15 - 14.67
52wk Range 4.720 - 15.57
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Small-Cap Stocks with Questionable Fundamentals
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
News headline image
NeoGenomics (NEO) Stock Trades Up, Here Is Why
What Happened? Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 3.4% in the afternoon session after the company announced the ... 
Via StockStory
Topics Intellectual Property Lawsuit

Performance

YTD
+23.3%
+23.3%
1 Month
+30.7%
+30.7%
3 Month
+67.1%
+67.1%
6 Month
+9.7%
+9.7%
1 Year
+110.1%
+110.1%

More News

Read More
News headline image
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
From NeoGenomics, Inc.
Via Business Wire
NeoGenomics Inc (NASDAQ:NEO) Crushes Estimates on Robust Clinical Growth, Launches Novel MRD Test ↗
Via Chartmill
News headline image
NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack
Via StockStory
News headline image
NeoGenomics Appoints Carolyn Starrett to its Board of Directors
From NeoGenomics, Inc.
Via Business Wire
News headline image
1 Unprofitable Stock for Long-Term Investors and 2 Facing Headwinds
Via StockStory
News headline image
NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present New Research at ASCO Annual Meeting 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Participate in Upcoming Investor Conferences
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know
Via StockStory
Topics Economy
News headline image
3 Russell 2000 Stocks We’re Skeptical Of
Via StockStory
News headline image
3 Reasons NEO is Risky and 1 Stock to Buy Instead
Via StockStory
Topics Bankruptcy Stocks Supply Chain
News headline image
5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call
Via StockStory
Topics Earnings
News headline image
NEO Q1 Deep Dive: High-Value Test Expansion and Commercial Execution Drive Oncology Growth
Via StockStory
News headline image
NeoGenomics (NEO) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
NeoGenomics (NEO) Q1 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
NeoGenomics’s (NASDAQ:NEO) Q1 CY2026: Beats On Revenue
Via StockStory
News headline image
NeoGenomics Reports First Quarter 2026 Results
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics NEO Q2 2025 Earnings Transcript ↗
Via The Motley Fool
Topics Retirement
News headline image
NeoGenomics Earnings: What To Look For From NEO
Via StockStory
News headline image
Why NeoGenomics (NEO) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence
News headline image
NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration
From NeoGenomics, Inc.
Via Business Wire

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 14.50
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 07/15/26 04:00 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 1.78B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.